- Home Page /
- Books /
- Medical Books /
- Pharmacology /
- Cell Therapy, Bispecific Antibodies and other Immunothe...
Cell Therapy, Bispecific Antibodies and other Immunotherapies Against Cancer
INR 8125
Price Details
Price
M.R.P. INR 9397
Excluding Shipping & Custom charges ( Shipping and custom charges will be calculated on checkout )
*All items will import from US
14%
QTY:
Ubuy works hard to protect your security and privacy. Our advanced payment security system ensures confidentiality by encrypting your information during transmission using AES (Advanced Encryption Standards) and SSL (Secure Socket Layer) protocols. Your payment details are 100% secure as we do not share your payment details with third party sellers.
This Special Issue highlights novel approaches to cell therapies, bispecific antibodies, vaccines, and immunotherapies that will be interesting for cancer cell researchers, biologists, and oncologists.
Fast
Shipping
Free
Return*
Secure Packaging
100% Original Products
PCI DSS Compliance
ISO 27001 Certified
What Stands Out
Product Details
- This Special Issue in Cancers is focused on cell therapy, bispecific antibodies, and other immunotherapies against cancer. It includes reports on cell therapies such as CAR-NK cell therapies, and bispecific antibodies against multiple myeloma and B cell lymphoma. Immunotherapies against solid tumors include TGF-beta-PDL-1 fusion protein and EpCAM-CD3 bispecific antibody generated with mRNA-lipid nanoparticles (LNP) against colorectal tumors. The clinical studies ongoing with bi- and tri-specific T cell engager antibodies against solid tumors and advantages versus cell therapies are discussed. This Special Issue highlights novel approaches to cell therapies, bispecific antibodies, vaccines, and immunotherapies that will be interesting for cancer cell researchers, biologists, and oncologists.
| Publisher | Mdpi AG |
| Publication date | November 29, 2023 |
| Language | English |
| Print length | 194 pages |
| ISBN-10 | 303659566X |
| ISBN-13 | 978-3036595665 |
| Item Weight | 1.37 pounds (620 grams) |
| Dimensions | 6.69 x 0.69 x 9.61 inches (17 x 1.8 x 24.4 cm) |
Who Should Buy?
-
Oncologists and Researchers
Ideal for medical professionals engaged in cancer research, providing comprehensive insights into cutting-edge immunotherapeutic techniques.
-
Medical Students
Beneficial for students specializing in oncology or immunotherapy, enhancing their education with current treatment methodologies and innovations.
-
Cancer Care Advocates
Useful for organizations and advocates seeking detailed information on advanced cancer treatments to better support patients.
-
General Public
Not suitable for casual readers without a medical background, as it contains complex terminology and specialized content.
Product Description
Customer Questions & Answers
-
Question:
What topics are covered in this Special Issue?
Answer: The Special Issue covers cell therapies, bispecific antibodies, immunotherapy approaches against various cancers, and ongoing clinical studies. -
Question:
Who would benefit from reading this Special Issue?
Answer: Cancer cell researchers, biologists, and oncologists will find valuable insights and updates in this issue. -
Question:
When is the publication date of this Special Issue?
Answer: The Special Issue is set to be published on November 29, 2023.
Vita Golubovskaya (Editor) Format: Hardcover Pharmacology Editorial Review
Customer Reviews & Ratings
-
5 Star
100%
-
4 Star
0%
-
3 Star
0%
-
2 Star
0%
-
1 Star
0%
Review this product
Share your thoughts with other customers
Platform Trust & Buyer Confidence
“logistcs is very good”
“Very good and seamless experience, delivery package came in very good condition”
“Heavy import cost and DHL's high delivery fees.”
“Interesting book and the seller describe it thank you”
“Excellent quality and a perfect fit. Description and measurements provided are to the point. Keep them coming more 🤟🏻”
Product Price History
Important information
- Limitations : For products shipped internationally, please note that any manufacturer warranty may not be valid; manufacturer service options may not be available; product manuals, instructions, and safety warnings may not be in destination country languages; the products (and accompanying materials) may not be designed in accordance with destination country standards, specifications, and labeling requirements; and the products may not conform to destination country voltage and other electrical standards (requiring use of an adapter or converter if appropriate). The recipient is responsible for assuring that the product can be lawfully imported to the destination country. When ordering from Ubuy or its affiliates, the recipient is the importer of record and must comply with all laws and regulations of the destination country.
- Not all the products listed on Ubuy are for sale, as Ubuy is a global search engine. Products are subject to export/trade regulations.
INR 8125
Order now and get it around Tuesday, August 04
This item is not restrict in my country.(Please click on above link if this item is not restrict in your country, So our team will review and allow.)
QTY:
PCI DSS compliant and ISO 27001:2022 certified, with encrypted payments and full buyer protection on every order.
Features & Benefits
- Explore cutting-edge cell therapies, including CAR-NK treatments.
- Gain insights into bispecific antibodies targeting multiple myeloma and B cell lymphoma.
- Discover innovative immunotherapies for solid tumors, like TGF-beta-PDL-1 fusion protein.
- Learn about mRNA-lipid nanoparticle generated bispecific antibodies for colorectal cancers.
- Stay updated on clinical studies of tri-specific T cell engager antibodies.
- Essential resource for cancer researchers, biologists, and oncologists.
Ubuy Assurance
Experience worry-free shopping with 100% original products, PCI DSS-compliant payment security, ISO 27001-certified data protection, the fastest cross-border delivery, free returns *, and secure packaging on every order.

